The FeNO by NIOX® podcast

Listen to our latest podcast on World Asthma Day and learn how important this day is for asthma sufferers.

Our latest podcast explores how FeNO testing can help to safely titrate inhaled corticosteroid dosages.

In this episode, learn about the updates regarding FeNO testing to the recently released NICE/BTS/SIGN Guidelines in the UK on the diagnosis and management of asthma.

Our latest podcast explores how cold weather can affect your patients’ respiratory conditions, such as asthma. It breaks down the risks, and how you can help support proactive care this cold season with FeNO testing.

Find out in our latest podcast about how FeNO could help to reduce healthcare costs, the potential savings to the UK and US healthcare systems, whilst helping improve patient outcomes. Listen here.

Are you new to FeNO testing or wondering how to get started? This episode of Five Minute FeNO breaks down everything you need to know about starting FeNO testing. From exploring what it is, how it can benefit you and your patients, to navigating reimbursement in the US. Listen today!

Welcome back to the five-minute FeNO Podcast with NIOX®, your go-to podcast for quick insights into FeNO testing. Today, we are diving into the topic of how smoking affects FeNO levels, and what this means for managing asthma with FeNO testing.

Welcome back to Five-minute FeNO. In this episode we are looking at how to ease the burden of pollution for asthma, including in paediatrics.

Welcome back to Five-minute FeNO. In this episode we are looking at understanding Type 2 inflammation pathways and predictive biomarkers.

Welcome back to the FeNO by NIOX® podcast. As allergy season, also known as hay fever season, approaches, many patients can find that their asthma symptoms get worse.1 In this episode we will look at why this could be, and how you can help your patients best manage their asthma alongside their hay fever during this period.

In 2023, a special report was published detailing the results of the Wessex AHSN FeNO Programme in England. The headline statistics were impressive. Thanks to the programme, 58,000 new asthmatics were diagnosed, more than 1,200 additional FeNO testing devices became available to primary care patients, 53% of primary care networks in England had access to FeNO testing as a result and almost 5,000 h...

Did you know the world’s first FeNO testing machine was developed by the team behind NIOX®? It was 1.5m tall and 70cm wide! Our cutting-edge technology has come a long way since then. So this time, here’s a little about the story of the FeNO evolution. 

Fractional exhaled nitric oxide, known as FeNO, testing and spirometry can make a valuable pairing in asthma care. In this episode, we’re looking at how these two pieces of the respiratory puzzle can help to complete the picture.

Testing a patient’s level of fractional exhaled nitric oxide, known as FeNO, is a valuable tool in asthma diagnosis and management so it’s important to know you can rely on the results.1 In this episode, we’re explaining how FeNO testing with NIOX® makes it possible.

We spoke to FeNO expert Professor Kjell Alving about the science behind foods that affect a patient’s level of fractional exhaled nitric oxide, or FeNO. There’s more to it than meets the eye so let’s get started.

As athletes strive to achieve their goals, one area of increasing focus is the role of respiratory health in sports performance. Studies show that FeNO testing is one of the tools that can help. FeNO isn’t just for elite performers either. The role of FeNO in the management of daily exercise-induced problems among school children has also been examined. Today, we’re talking about some of the highl...

Research has shown that cigarette smoking can reduce fractional exhaled nitric oxide – or FeNO – by around 60%1but what about vaping? Electronic or ‘e-cigarettes’ have gained significant popularity in recent years as an alternative to traditional tobacco smoking. However, concerns  have  been raised regarding the potential impact on public health. One aspect of particular interest to the respirato...

Devices that measure FeNO have markedly influenced the clinical decision-making of healthcare professionals and helped alter treatment plans for patients with asthma. However, true accuracy and reproducibility of the results depend on various factors, including the proper use of the FeNO testing device. In this episode, we discuss the value of audio guides as part of this process.

This month marks 25 years of FeNO testing by NIOX®, a company founded by the same scientists who originally discovered its benefits in asthma care.

To mark World Asthma Day, in this episode our lead nurse for education and support, Karen Frankland, talks to broadcaster Will Luscombe to discuss how asthma treatment can be enhanced with the help of FeNO testing.

A FeNO level greater than 40 parts per billion – or ppb – means asthma is seven times more likely, making FeNO a useful biomarker in suspected cases. But why is FeNO higher in asthma patients? This episode looks at the science.

Over-reliance on short-acting β2-agonists, known as SABA, may indicate poor asthma control. Some people are collecting more than 50 canisters a year when the recommendation is one or two! In this episode, we look at the facts and...

In this episode, we’re looking at what is important when measuring FeNO levels and how the technology behind NIOX VERO® addresses these needs.

One part per billion. It’s difficult to picture it but this microscopic measure is an intrinsic element of the technology behind FeNO testing and its practical application in asthma care.

As many people know, FeNO stands for fractional exhaled nitric oxide. Changes in individual FeNO levels provide vital clues to how asthma treatment is working. Interpreting the variations is quite straightforward. This episode looks in detail at using FeNO testing to achieve everyone’s personal best.